In the latest session, Bionano Genomics Inc (NASDAQ: BNGO) closed at $0.98 down -5.10% from its previous closing price of $1.03. On the day, 1863633 shares were traded.
Ratios:
For a deeper understanding of Bionano Genomics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on January 05, 2023, initiated with a Sector Outperform rating and assigned the stock a target price of $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’23 when Mamuszka Hannah bought 65,789 shares for $0.76 per share. The transaction valued at 50,000 led to the insider holds 65,789 shares of the business.
Holmlin R. Erik bought 15,000 shares of BNGO for $9,639 on May 16 ’23. The President and CEO now owns 806,474 shares after completing the transaction at $0.64 per share. On May 12 ’23, another insider, Stewart Christopher P., who serves as the Chief Financial Officer of the company, bought 50,000 shares for $0.67 each. As a result, the insider paid 33,415 and bolstered with 281,373 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.66 while its Price-to-Book (P/B) ratio in mrq is 0.47.
Stock Price History:
Over the past 52 weeks, BNGO has reached a high of $11.80, while it has fallen to a 52-week low of $0.96.
Shares Statistics:
A total of 61.23M shares are outstanding, with a floating share count of 60.58M. Insiders hold about 1.07% of the company’s shares, while institutions hold 10.09% stake in the company.
Earnings Estimates
There are Bionano Genomics, Inc. different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $0.33, with high estimates of $28.58 and low estimates of $6.37.
